2m 2m 2m 2m 2m 2m 2m
KALARIS THERAP (KLRS)
NASDAQ
$3.43+$0.05 (+1.48%)
Price as of Sep 11, 2026 7:30 PM EDT- $80.5MMarket Cap
- -13.11%1-Year Change
- BiotechnologyIndustry
KALARIS THERAP (KLRS)
$3.43+$0.05 (+1.48%)
KLRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.38 | ||
Change | +$0.08 (+2.42%) | ||
Open | $3.39 | ||
High | $3.44 | ||
Low | $3.27 | ||
Previous Close | $3.30 | ||
Volume | 95,102 | ||
30-Day Average Volume | 53,797 | ||
1-Week Change | -13.33% | ||
1-Month Change | -14.86% | ||
1-Year Change | -13.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.8M | ||
Total Assets | $99.5M | ||
Market Cap | $80.5M | ||
Enterprise Value | $37.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.0M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.5M | ||
Net Working Capital | $87.2M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 2 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue